Galibier Capital Management Ltd. Lowers Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Galibier Capital Management Ltd. trimmed its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 19.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,476 shares of the company's stock after selling 10,000 shares during the quarter. Henry Schein comprises 0.9% of Galibier Capital Management Ltd.'s investment portfolio, making the stock its 19th biggest holding. Galibier Capital Management Ltd.'s holdings in Henry Schein were worth $2,841,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in HSIC. Proficio Capital Partners LLC acquired a new stake in Henry Schein during the 4th quarter worth approximately $943,000. Raymond James Financial Inc. purchased a new position in shares of Henry Schein during the 4th quarter worth approximately $34,720,000. Edgestream Partners L.P. raised its stake in shares of Henry Schein by 119.5% during the 4th quarter. Edgestream Partners L.P. now owns 10,472 shares of the company's stock worth $725,000 after buying an additional 5,702 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Henry Schein by 0.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 86,601 shares of the company's stock worth $5,993,000 after buying an additional 458 shares in the last quarter. Finally, Amundi raised its stake in shares of Henry Schein by 12.0% during the 4th quarter. Amundi now owns 736,637 shares of the company's stock worth $52,345,000 after buying an additional 79,056 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Trading Down 1.5%

Shares of NASDAQ:HSIC traded down $1.11 during midday trading on Friday, reaching $73.42. The company's stock had a trading volume of 1,446,652 shares, compared to its average volume of 1,727,684. The firm has a market cap of $8.94 billion, a price-to-earnings ratio of 22.94, a price-to-earnings-growth ratio of 2.37 and a beta of 0.87. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The business has a 50 day moving average price of $71.56 and a 200 day moving average price of $71.33.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The business's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.10 earnings per share. Research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HSIC. Piper Sandler cut their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Evercore ISI lifted their price objective on Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a report on Wednesday. Wells Fargo & Company reduced their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Finally, Barrington Research dropped their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $79.70.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.